Biophytis Stock Today
| BPTS Stock | USD 8.02 1.40 14.86% |
Performance0 of 100
| Odds Of DistressOver 72
|
Biophytis is selling for under 8.02 as of the 14th of May 2024; that is -14.86 percent down since the beginning of the trading day. The stock's lowest day price was 8.02. Biophytis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Biophytis are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 14th of February 2024 and ending today, the 14th of May 2024. Click here to learn more.
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was incorporated in 2006 and is headquartered in Paris, France. The company has 286.5 K outstanding shares of which 368.95 K shares are currently shorted by private and institutional investors with about 0.41 trading days to cover. More on Biophytis
Moving together with Biophytis Stock
| 0.84 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.62 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.87 | BKRKY | Bank Rakyat | PairCorr |
| 0.67 | PTBRY | Bank Negara Indonesia | PairCorr |
Moving against Biophytis Stock
| 0.92 | GE | GE Aerospace Financial Report 23rd of July 2024 | PairCorr |
| 0.9 | AA | Alcoa Corp Buyout Trend | PairCorr |
| 0.82 | AXP | American Express Financial Report 19th of July 2024 | PairCorr |
| 0.81 | XOM | Exxon Mobil Corp Financial Report 26th of July 2024 | PairCorr |
| 0.6 | KO | Coca Cola Aggressive Push | PairCorr |
| 0.52 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
| 0.49 | PG | Procter Gamble Financial Report 26th of July 2024 | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biophytis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biophytis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biophytis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Biophytis (BPTS) is traded on NASDAQ Exchange in USA and employs 22 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.61 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biophytis's market, we take the total number of its shares issued and multiply it by Biophytis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biophytis conducts business under Biotechnology sector and is part of Health Care industry. The entity has 286.5 K outstanding shares of which 368.95 K shares are currently shorted by private and institutional investors with about 0.41 trading days to cover.
Biophytis currently holds about 23.93 M in cash with (13.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check Biophytis Probability Of Bankruptcy
Ownership AllocationAlmost 100.0 percent of Biophytis outstanding shares are held by general public with 0.04 % by other corporate entities.
Check Biophytis Ownership Details
Biophytis Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Biophytis jumping above the current price in 90 days from now is under 95%. The Biophytis probability density function shows the probability of Biophytis stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Biophytis has a beta of -2.5359 suggesting as returns on its benchmark rise, returns on holding Biophytis are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Biophytis is expected to outperform its benchmark. Additionally, biophytis has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Biophytis to move above the current price in 90 days from now is under 95 (This Biophytis probability density function shows the probability of Biophytis Stock to fall within a particular range of prices over 90 days) .
Biophytis Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biophytis market risk premium is the additional return an investor will receive from holding Biophytis long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biophytis. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Biophytis' alpha and beta are two of the key measurements used to evaluate Biophytis' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 6.32 | |||
| Standard Deviation | 9.34 | |||
| Variance | 87.23 | |||
| Risk Adjusted Performance | (0.05) |
Biophytis Stock Against Markets
Picking the right benchmark for Biophytis stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biophytis stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biophytis is critical whether you are bullish or bearish towards Biophytis at a given time. Please also check how Biophytis' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biophytis without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Biophytis Corporate Management
Elected by the shareholders, the Biophytis' board of directors comprises two types of representatives: Biophytis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biophytis. The board's role is to monitor Biophytis' management team and ensure that shareholders' interests are well served. Biophytis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biophytis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edouard Bieth | Chief Officer | Profile | |
| Philippe Rousseau | Chief Officer | Profile | |
| Waly Dioh | Chief Officer | Profile | |
| Pierre Dilda | Chief Officer | Profile | |
| Benoit Canolle | Chief Officer | Profile | |
| Stanislas Veillet | Chairman CEO | Profile | |
| Rene Lafont | Scientific Board | Profile |
How to buy Biophytis Stock?
Before investing in Biophytis, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biophytis. To buy Biophytis stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biophytis. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biophytis stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biophytis stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biophytis stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biophytis, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Biophytis Stock please use our How to Invest in Biophytis guide.
Already Invested in Biophytis?
The danger of trading Biophytis is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biophytis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biophytis. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biophytis is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biophytis is a strong investment it is important to analyze Biophytis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biophytis' future performance. For an informed investment choice regarding Biophytis Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biophytis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Biophytis Stock please use our How to Invest in Biophytis guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Biophytis Stock analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Biophytis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biophytis. If investors know Biophytis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biophytis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biophytis is measured differently than its book value, which is the value of Biophytis that is recorded on the company's balance sheet. Investors also form their own opinion of Biophytis' value that differs from its market value or its book value, called intrinsic value, which is Biophytis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biophytis' market value can be influenced by many factors that don't directly affect Biophytis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biophytis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biophytis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biophytis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.